Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.1.21 (
thymidine kinase
)
7,561
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In this study, an entire open reading frame encoding the capsid protein of feline calicivirus (FCV) F4 strain was inserted into the deletion locus (SmaI site) of the
thymidine kinase
(TK) deficient mutant (C7301dlTK) of feline herpesvirus type 1 (FHV-1) and the resulting recombinant virus was designated as C7301dlTK-
Cap
. Expression of the FCV antigens by C7301dlTK-
Cap
was confirmed by indirect immunofluorescence assay and immunoblot analysis. To assess whether the recombinant virus can induce virus neutralizing (VN) antibody against FCV in the natural host, three cats were inoculated intranasally and orally with C7301dlTK-
Cap
(two cats) or C7301dlTK (one cat). As a result, sera collected from cats inoculated with the C7301dlTK-
Cap
possessed VN antibody against FCV. This recombinant virus is expected as a new polyvalent recombinant vaccine against FHV-1 and FCV infections.
...
PMID:Recombinant feline herpesvirus type 1 expressing immunogenic proteins inducible virus neutralizing antibody against feline calicivirus in cats. 903 96
We previously constructed a recombinant feline herpesvirus type 1 (FHV1), C7301dlTK-
Cap
, which contains an entire open reading frame encoding the capsid protein of feline calicivirus (FCV) F4 strain in the deleted locus of the
thymidine kinase
(TK) deficient mutant (C7301dlTK) of FHV1. In this report, we carried out in vivo experiments to assess the vaccine efficacy of the recombinant C7301dlTK-
Cap
against FCV and FHV1 infections in cats. As a result, two vaccinations with the C7301dlTK-
Cap
by intraocular, intranasal and oral routes protected cats to a significant degree against subsequent virulent challenges with both parent FCV F4 and FHV1 C7301 strains. The results are applicable for the further development of a new genetically engineered polyvalent vaccine for cats.
...
PMID:Vaccine efficacy of recombinant feline herpesvirus type 1 expressing immunogenic proteins of feline calicivirus in cats. 952 41
We previously reported the attenuation of
thymidine kinase
(TK) deficient mutant (C7301dlTK) of feline herpesvirus type 1 (FHV-1) in cats and the construction of a recombinant FHV-1 (C7301dlTK-
Cap
) inserted a precursor capsid gene of feline calcivirus (FCV) into the TK deletion locus of the C7301dlTK. In this study, we constructed a further improved recombinant FHV-1 (dlTK(gCp)-
Cap
) carrying a putative FHV-1 gC promoter sequence upstream of the FCV precursor capsid gene of the C7301dlTK-
Cap
. Growth kinetics of the dlTK(gCp)-
Cap
in cell cultures was similar to those of C7301dlTK and C7301dlTK-
Cap
. A strong expression of FCV immunogenic antigen by dlTK(gCp)-
Cap
was confirmed by indirect immunofluorescence and enzyme-linked immunosorbent assays. In addition, one vaccination with dlTK(gCp)-
Cap
protected cats more effective against subsequent virulent FCV challenge than that with C7301dlTK-
Cap
.
...
PMID:Further development of a recombinant feline herpesvirus type 1 vector expressing feline calicivirus immunogenic antigen. 967 43